|
|
 |
 |
Mark R. Hutchins, M.D. 
“Caring for each individual, as a unique person, is as important to me as treating disease.” |
- Undergraduate degree with Distinction, University of Nebraska, Lincoln: Member Phi Beta Kappa, 1974
- Graduate, University of Nebraska School of Medicine, 1976
- Completed Residency in Internal Medicine, University of Oklahoma, 1979
- Completed Fellowship in Hematology-Oncology, University of Oklahoma, 1981
- Board Certified Internal Medicine
- Board Certified Medical Oncology
- In practice since 1981
|
 |
 |
Daniel F. Moravec, Jr., M.D.
“As oncologists, we are here to coordinate every aspect of cancer treatment. My goal is that each patient receives exactly the treatment they need, when they need it, from the best possible source.” |
- Graduate, University of Nebraska Medical Center College of Pharmacy with High Distinction, 1973
- Graduate, University of Nebraska School of Medicine, with Distinction, 1976
- Internship in Pathology, University of Nebraska Medical Center, 1976
- Completed Residency in Internal Medicine, University of Nebraska Medical Center, 1980
- Completed Fellowship in Hematology-Oncology, University of Iowa, 1982
- Member Alpha Omega Alpha Medical Honorary Society
- Rho Chi National Pharmaceutical Honorary Society
- Board Certified Internal Medicine
- Board Certified Medical Oncology
- In practice since 1982
|
|
 |
Joni A. Tilford, M.D.
“Our ongoing involvement in clinical trials keeps us in tune with the latest advancements in cancer care. The people we treat deserve the best, and we make sure they get it.” |
- Undergraduate degree, Nebraska Wesleyan University, 1991, BS in Biology with Math minor
- Graduate, University of Nebraska School of Medicine, 1997
- Completed Residency in Internal Medicine, University of Nebraska Medical Center, 2000
- Completed Fellowship in Hematology-Oncology, University of Nebraska Medical Center, 2002
- Board Certified Internal Medicine
- Board Certified Medical Oncology
- Dr. Tilford has a broad background in both clinical and laboratory medicine and has authored scientific articles in molecular genetics, thrombosis, and leukemia.
- In practice since 2002
|
|
 |
Madhu V. Midathada, M.D.
“We strive to develop the optimum treatment strategy for each person based on their medical background, current health, and personal preferences. Everything we do is individualized to offer the best outcome possible.” |
- Graduate, Andhra Medical College, University of Health Sciences, Visakhapatnam, India, 1992
- Completed Rotational Internship, King George Hospital, Visakhapatnam, India, 1994
- Completed Residency in Internal Medicine, Coney Island Hospital, SUNY Health Science Center, New York, 2002
- Completed Fellowship in Hematology-Oncology, University of Arkansas for Medical Sciences, 2005
- Merit Award Winner, American Society of Clinical Oncology, 2004 and 2005
- Board Certified Internal Medicine
- Board Certified Hematology and Medical Oncology
- Broad research background in hematology and oncology at UAMS and in laboratory medicine at Centers for Disease Control, Atlanta
- Published scientific papers in American Society of Clinical Oncology, American Journal of Clinical Pathology, Journal of Infectious Diseases, and Clinical Advances in Hematology & Oncology
- In practice since 2005
|
|
|
 |
|
